|
|
H2022/CTD9302/20844
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG / 200 MG / 25 MG
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG / 200 MG / 25 MG
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9547/18539
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/200 MG/25 MG
|
DOLUTEGRAVIR SODIUM, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD8409/16370
|
SPEGRA
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD8336/15579
|
BIKTARVY
|
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD6488/12689
|
DESCOVY 200 MG/25MG
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD6687/12231
|
DESCOVY 200MG/10MG
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD9303/18618
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 200 MG / 25 MG
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2026/CTD12201/24556
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG, 300 MG AND 25 MG
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG, 300 MG AND 25 MG
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10906/21966
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/300 MG/25 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9937/21860
|
ENVUTEG
|
LAMIVUDINE USP , TENOFOVIR ALAFENAMIDE AND DOLUTEGRAVIR
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7081/18177
|
KOCITAF
|
DOLUTEGRAVIR SODIUM/ EMTRICITABINE/ TENOFOVIR ALAFENAMIDE FUMARATE
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7411/14564
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG TABLETS
|
EACH FILM COATED TABLET CONTAINS 52.6 MG OF DOLUTEGRAVIR SODIUM EQUIVALENT TO 50 MG OF DOLUTEGRAVIR, 300 MG OF LAMIVUDINE USP AND 300 MG OF TENOFOVIR DISOPROXIL FUMARATE (EQUIVALENT TO 245 MG OF TENOFOVIR DISOPROXIL).
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7411/14564/R1
|
Dolutegravir Lamivudine and Tenofovir Disoproxil…
|
Each film coated tablet contains 52.6 mg of…
|
M/s. Hetero Labs Limited
|
Retained
|
Details →
|
|
|
CTD6639
|
ACRIPTEGA
|
LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE AND DOLUTEGRAVIR
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7980/16504
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7079/13566
|
DOLUTEGRAVIR 50MG , LAMIVUDINE 300MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS
|
DOLUTEGRAVIR SODIUM,LAMIVUDINE USP TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD7411
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8639/19826
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50/300/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
EVKA CONSULTZ LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8566/18403
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
TIBA HEALTHCARE LIMITED
|
Registered
|
Details →
|
|
|
H2025/CTD11527/23967
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG / 300 MG / 300 MG TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE
|
MICRO LABS (EA) LTD
|
Registered
|
Details →
|